
CCCC Valuation
C4 Therapeutics Inc
- Overview
- Forecast
- Valuation
- Earnings
CCCC Relative Valuation
CCCC's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, CCCC is overvalued; if below, it's undervalued.
Historical Valuation
C4 Therapeutics Inc (CCCC) is now in the Fair zone, suggesting that its current forward PS ratio of 5.61 is considered Fairly compared with the five-year average of -6.58. The fair price of C4 Therapeutics Inc (CCCC) is between 1.76 to 18.53 according to relative valuation methord.
Relative Value
Fair Zone
1.76-18.53
Current Price:2.17
Fair
Trailing
Forward
P/E
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
0.61
P/B
Median3y
1.14
Median5y
2.09
-65.53
FCF Yield
Median3y
-47.16
Median5y
-32.04
Competitors Valuation Multiple
The average P/S ratio for CCCC's competitors is 6.75, providing a benchmark for relative valuation. C4 Therapeutics Inc Corp (CCCC) exhibits a P/S ratio of , which is -100.00% above the industry average. Given its robust revenue growth of 138.17%, this premium appears sustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
P/S
People Also Watch

PAL
Proficient Auto Logistics Inc
7.430
USD
+2.34%

NVX
NOVONIX Ltd
1.640
USD
-9.89%

EM
Smart Share Global Ltd
1.140
USD
0.00%

YMAB
Y-mAbs Therapeutics Inc
4.410
USD
+1.85%

VYGR
Voyager Therapeutics Inc
3.160
USD
-0.32%

CBAN
Colony Bankcorp Inc
17.730
USD
+0.62%

PLBC
Plumas Bancorp
43.070
USD
+0.70%

PCB
PCB Bancorp
21.510
USD
-0.51%

PCYO
Pure Cycle Corp
10.000
USD
+1.21%

SATL
Satellogic Inc
3.620
USD
+5.54%
FAQ

Is C4 Therapeutics Inc (CCCC) currently overvalued or undervalued?
C4 Therapeutics Inc (CCCC) is now in the Fair zone, suggesting that its current forward PS ratio of 5.61 is considered Fairly compared with the five-year average of -6.58. The fair price of C4 Therapeutics Inc (CCCC) is between 1.76 to 18.53 according to relative valuation methord.

What is C4 Therapeutics Inc (CCCC) fair value?

How does CCCC's valuation metrics compare to the industry average?

What is the current P/B ratio for C4 Therapeutics Inc (CCCC) as of Jul 23 2025?

What is the current FCF Yield for C4 Therapeutics Inc (CCCC) as of Jul 23 2025?

What is the current Forward P/E ratio for C4 Therapeutics Inc (CCCC) as of Jul 23 2025?
